Dose-dense chemotherapy for breast cancer: what does the future hold?
about
Current advances in mathematical modeling of anti-cancer drug penetration into tumor tissuesTargeting the interleukin-6/Jak/stat pathway in human malignanciesSerious neutropenia following neoadjuvant chemotherapy for locally advanced breast cancer: A case reportAdvanced Urothelial Carcinoma: Overcoming Treatment Resistance through Novel Treatment Approaches.Translating mathematical modeling of tumor growth patterns into novel therapeutic approaches for breast cancer.Lipegfilgrastim for the prophylaxis and treatment of chemotherapy-induced neutropenia.
P2860
Dose-dense chemotherapy for breast cancer: what does the future hold?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dose-dense chemotherapy for breast cancer: what does the future hold?
@en
Dose-dense chemotherapy for breast cancer: what does the future hold?
@nl
type
label
Dose-dense chemotherapy for breast cancer: what does the future hold?
@en
Dose-dense chemotherapy for breast cancer: what does the future hold?
@nl
prefLabel
Dose-dense chemotherapy for breast cancer: what does the future hold?
@en
Dose-dense chemotherapy for breast cancer: what does the future hold?
@nl
P2093
P2860
P356
P1433
P1476
Dose-dense chemotherapy for breast cancer: what does the future hold?
@en
P2093
Clifford Hudis
Heather L McArthur
Patrick G Morris
P2860
P304
P356
10.2217/FON.10.59
P407
P50
P577
2010-06-01T00:00:00Z